(Q87461749)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

review article

3 references

13 July 2022

22 October 2022

Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

0 references

0 references

0 references

0 references

0 references

0 references

1 reference

People's Republic of China

0 references

5

Shibo Jiang

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

2

Lanying Du

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

Fei Yu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

4

Chungen Pan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

author name string

David M Ojcius

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

language of work or name

English

0 references

publication date

1 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

1 March 2020

2 references

13 July 2022

22 October 2022

Microbes and Infection

3 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

13 July 2022

22 October 2022

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

page(s)

74-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity

6 April 2020

cites work

1 reference

12 December 2020

A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination

1 reference

12 December 2020

HIV-1 inhibition by a peptide

1 reference

12 December 2020

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

1 reference

12 December 2020

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

1 reference

12 December 2020

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

1 reference

12 December 2020

Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors

1 reference

12 December 2020

Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity

1 reference

12 December 2020

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus

1 reference

12 December 2020

Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine

1 reference

12 December 2020

Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry

1 reference

12 December 2020

Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines

1 reference

12 December 2020

Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies

1 reference

12 December 2020

Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants

1 reference

12 December 2020

Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein.

1 reference

12 December 2020

Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV

1 reference

12 December 2020

Pacing a small cage: mutation and RNA viruses

1 reference

12 December 2020

A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

1 reference

12 December 2020

Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway

1 reference

12 December 2020

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

1 reference

12 December 2020

Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential

1 reference

12 December 2020

The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry

1 reference

12 December 2020

Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction

1 reference

12 December 2020

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

1 reference

12 December 2020

Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein

1 reference

12 December 2020

Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests

1 reference

12 December 2020

Specific serology for emerging human coronaviruses by protein microarray

1 reference

12 December 2020

Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC.

1 reference

12 December 2020

A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV

1 reference

12 December 2020

Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012.

1 reference

12 December 2020

Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate

1 reference

12 December 2020

Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus

1 reference

12 December 2020

Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor

1 reference

12 December 2020

Current advancements and potential strategies in the development of MERS-CoV vaccines

1 reference

12 December 2020

Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution

1 reference

12 December 2020

Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP).

1 reference

12 December 2020

Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study.

1 reference

12 December 2020

Protective Efficacy of Recombinant Modified Vaccinia Virus Ankara Delivering Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein

1 reference

12 December 2020

Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection

1 reference

12 December 2020

Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus

1 reference

12 December 2020

Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review

1 reference

12 December 2020

Middle East respiratory syndrome: current status and future prospects for vaccine development

1 reference

12 December 2020

Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus

1 reference

12 December 2020

Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection

1 reference

12 December 2020

T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.

1 reference

12 December 2020

One-Pot Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) for Detecting MERS-CoV.

1 reference

12 December 2020

Development of Dual TaqMan Based One-Step rRT-PCR Assay Panel for Rapid and Accurate Diagnostic Test of MERS-CoV: A Novel Human Coronavirus, Ahead of Hajj Pilgrimage.

1 reference

12 December 2020

Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR.

1 reference

12 December 2020

DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice

1 reference

12 December 2020

Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains

1 reference

12 December 2020

Multiplex Paper-Based Colorimetric DNA Sensor Using Pyrrolidinyl Peptide Nucleic Acid-Induced AgNPs Aggregation for Detecting MERS-CoV, MTB, and HPV Oligonucleotides

1 reference

12 December 2020

Human Neutralizing Monoclonal Antibody Inhibition of Middle East Respiratory Syndrome Coronavirus Replication in the Common Marmoset.

1 reference

12 December 2020

Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses.

1 reference

12 December 2020

Evaluation and Clinical Validation of Two Field-Deployable Reverse Transcription-Insulated Isothermal PCR Assays for the Detection of the Middle East Respiratory Syndrome Coronavirus

1 reference

12 December 2020

Establishment and Application of a Universal Coronavirus Screening Method Using MALDI-TOF Mass Spectrometry

1 reference

12 December 2020

Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses.

1 reference

12 December 2020

Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies

1 reference

12 December 2020

Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

1 reference

12 December 2020

Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape.

1 reference

12 December 2020

A Rapid and Specific Assay for the Detection of MERS-CoV.

1 reference

12 December 2020

Arch-shaped multiple-target sensing for rapid diagnosis and identification of emerging infectious pathogens

1 reference

12 December 2020

The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts

1 reference

12 December 2020

Advances in MERS-CoV Vaccines and Therapeutics Based on the Receptor-Binding Domain

1 reference

12 December 2020

A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike

1 reference

12 December 2020

Antibodies and vaccines against Middle East respiratory syndrome coronavirus

1 reference

12 December 2020

The Impact of Pre-existing Immunity on the Non-clinical Pharmacodynamics of AAV5-Based Gene Therapy

1 reference

12 December 2020

Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial

1 reference

12 December 2020

Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle

1 reference

12 December 2020

An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies

1 reference

12 December 2020

10.1016/J.MICINF.2020.01.003

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 April 2020

COVIDWHO ID

covidwho-118

0 references

1124482050

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

DOI

10.6084/M9.FIGSHARE.11961063

28 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json

6 April 2020

PubMed publication ID

32017984

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32017984%20AND%20SRC:MED&resulttype=core&format=json